Binghe Xu

3 articles listing Binghe Xu in Nature Communications, Science Advances, indexed by Paperzzz from Crossref and OSF.

1. Disitamab vedotin for HER2-positive breast cancer with liver metastases: phase 3 results from the RC48-C006 phase 2/3 trial Nature Communications
2. Afuresertib plus fulvestrant for pretreated HR-positive, HER2-negative, advanced breast cancer: a phase Ib trial Nature Communications
3. Multicellular force coordination constructs microchannel networks for barrier-free metastasis across extracellular matrix Science Advances